Enveric Biosciences, Inc. (ENVB)
1.42
+0.04
(+2.90%)
USD |
NASDAQ |
Oct 27, 16:00
1.44
+0.02
(+1.41%)
Pre-Market: 20:00
Enveric Biosciences Market Cap : 5.589M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 5.589M |
| October 26, 2026 | 5.432M |
| October 23, 2026 | 5.510M |
| October 22, 2026 | 5.746M |
| October 21, 2026 | 5.943M |
| October 20, 2026 | 5.668M |
| October 19, 2026 | 5.471M |
| October 16, 2026 | 5.432M |
| October 15, 2026 | 5.471M |
| October 14, 2026 | 5.392M |
| October 13, 2026 | 5.510M |
| October 12, 2026 | 5.786M |
| October 09, 2026 | 5.707M |
| October 08, 2026 | 5.983M |
| October 07, 2026 | 5.884M |
| October 06, 2026 | 5.786M |
| October 05, 2026 | 5.943M |
| October 02, 2026 | 5.825M |
| October 01, 2026 | 5.746M |
| September 30, 2026 | 5.845M |
| September 29, 2026 | 5.707M |
| September 28, 2026 | 5.786M |
| September 25, 2026 | 5.904M |
| September 24, 2026 | 6.081M |
| September 23, 2026 | 6.160M |
| Date | Value |
|---|---|
| September 22, 2026 | 6.061M |
| September 21, 2026 | 6.14M |
| September 18, 2026 | 6.376M |
| September 17, 2026 | 6.258M |
| September 16, 2026 | 5.864M |
| September 15, 2026 | 5.746M |
| September 14, 2026 | 5.825M |
| September 11, 2026 | 5.589M |
| September 10, 2026 | 5.746M |
| September 09, 2026 | 5.727M |
| September 08, 2026 | 5.589M |
| September 04, 2026 | 5.471M |
| September 03, 2026 | 5.668M |
| September 02, 2026 | 5.668M |
| September 01, 2026 | 5.392M |
| August 31, 2026 | 5.392M |
| August 28, 2026 | 5.392M |
| August 27, 2026 | 5.392M |
| August 26, 2026 | 5.392M |
| August 25, 2026 | 5.746M |
| August 24, 2026 | 5.550M |
| August 21, 2026 | 5.628M |
| August 20, 2026 | 5.471M |
| August 19, 2026 | 5.156M |
| August 18, 2026 | 5.314M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| LENZ Therapeutics, Inc. | 98.96M |
| Impact BioMedical, Inc. | 30.33M |
| ANI Pharmaceuticals, Inc. | 1.635B |
| Corcept Therapeutics, Inc. | 9.453B |
| Veru, Inc. | 38.87M |
Market Cap Related Metrics
| Price to Book Value | 0.6915 |
| Price | 1.42 |
| Earnings Yield | -1.16K% |